Last Updated : September 18, 2009
Details
FilesGeneric Name:
Eculizumab
Project Status:
Complete
Therapeutic Area:
Paroxysmal nocturnal hemoglobinuria (PNH)
Manufacturer:
Alexion Pharmaceuticals Inc.
Brand Name:
Soliris
Project Line:
Reimbursement Review
Project Number:
SR0176-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Paroxysmal nocturnal hemoglobinuria (PNH)
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : September 18, 2009